UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neuromelanin in Parkinson's Disease: Tyrosine Hydroxylase and Tyrosinase

International journal of molecular sciences, 2022-04, Vol.23 (8), p.4176

2022

Volltextzugriff (PDF)

NeuroPsychopharmacotherapy

1st ed. 2022., 2022

Volltextzugriff (PDF)

Remembering Keisuke Fujita, M.D., Ph.D., President and Founder of Fujita Health University, and his contributions to medical science and education

Fujita Medical Journal, 2022, Vol.8(1), pp.3-12

Nagatsu, Toshiharu

2022

Volltextzugriff (PDF)

Parkinson's Disease: Cells Succumbing to Lifelong Dopamine-Related Oxidative Stress and Other Bioenergetic Challenges

International journal of molecular sciences, 2024-02, Vol.25 (4), p.2009

2024

Volltextzugriff (PDF)

The Life and Science of Professor Tsuneko Okazaki, and her time at Fujita Health University

Fujita Medical Journal, 2024, Vol.10(1), pp.1-7

2024

Volltextzugriff (PDF)

L-dopa therapy for Parkinson's disease: Past, present, and future

Parkinsonism & related disorders, 2009, Vol.15, p.S3-S8

2009

Volltextzugriff (PDF)

Human tyrosine hydroxylase in Parkinson’s disease and in related disorders

Journal of Neural Transmission, 2019-04, Vol.126 (4), p.397-409

2019

Volltextzugriff (PDF)

Catecholamines and Parkinson’s disease: tyrosine hydroxylase (TH) over tetrahydrobiopterin (BH4) and GTP cyclohydrolase I (GCH1) to cytokines, neuromelanin, and gene therapy: a historical overview

Journal of Neural Transmission, 2024-06, Vol.131 (6), p.617-630

Nagatsu, Toshiharu

2024

Volltextzugriff (PDF)

In memory of Professor Leonor Michaelis in Nagoya: Great contributions to biochemistry in Japan in the first half of the 20th century

FEBS letters, 2013-09, Vol.587 (17), p.2721-2724

Nagatsu, Toshiharu (Toshi)

2013

Volltextzugriff (PDF)

Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains

Acta neuropathologica, 2003-12, Vol.106 (6), p.518-526

2003

Volltextzugriff (PDF)

Identification by nano-LC-MS/MS of NT5DC2 as a protein binding to tyrosine hydroxylase: Down-regulation of NT5DC2 by siRNA increases catecholamine synthesis in PC12D cells

Biochemical and biophysical research communications, 2019-09, Vol.516 (4), p.1060-1065

2019

Volltextzugriff (PDF)

Salivary neopterin and related pterins: their comparison to those in plasma and changes in individuals

Journal of biochemistry (Tokyo), 2021-12, Vol.170 (4), p.559-567

2021

Volltextzugriff (PDF)

Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson’s disease (PD): historical overview and future prospects

Journal of Neural Transmission, 2016-11, Vol.123 (11), p.1255-1278

2016

Volltextzugriff (PDF)

Hypothesis: neural mechanism of psychotherapy for the treatment of Parkinson’s disease: cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), and Morita therapy?

Journal of Neural Transmission, 2020-02, Vol.127 (2), p.273-276

Nagatsu, Toshiharu

2020

Volltextzugriff (PDF)

Marshall Warren Nirenberg, Honorary member of JSN: Nobel Laureate and Giant of Science

Neurochemistry international, 2012-11, Vol.61 (6), p.817-818

Nagatsu, Toshiharu (Toshi)

2012

Volltextzugriff (PDF)

The catecholamine system in health and disease: Relation to tyrosine 3-monooxygenase and other catecholamine-synthesizing enzymes

Proceedings of the Japan Academy, Series B, 2006, Vol.82(10), pp.388-415

NAGATSU, Toshiharu

2006

Volltextzugriff (PDF)

A link between stress and depression: Shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression

Stress (Amsterdam, Netherlands), 2008, Vol.11 (3), p.198-209

2008

Volltextzugriff (PDF)

NT5DC2 affects the phosphorylation of tyrosine hydroxylase regulating its catalytic activity

Journal of Neural Transmission, 2020-12, Vol.127 (12), p.1631-1640

2020

Volltextzugriff (PDF)

Inhibition of deubiquitinating activity of USP14 decreases tyrosine hydroxylase phosphorylated at Ser19 in PC12D cells

Biochemical and biophysical research communications, 2016-04, Vol.472 (4), p.598-602

2016

Volltextzugriff (PDF)

Correction to: Hypothesis: neural mechanism of psychotherapy for the treatment of Parkinson’s disease: cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), and Morita therapy?

Journal of Neural Transmission, 2020-02, Vol.127 (2), p.277-277

Nagatsu, Toshiharu

2020

Volltextzugriff (PDF)

Prolyl oligopeptidase and dipeptidyl peptidase II/dipeptidyl peptidase IV ratio in the cerebrospinal fluid in Parkinson’s disease: historical overview and future prospects

Journal of Neural Transmission, 2017-06, Vol.124 (6), p.739-744

Nagatsu, Toshiharu

2017

Volltextzugriff (PDF)

Isoquinoline neurotoxins in the brain and Parkinson's disease

Neuroscience Research, 1997-10, Vol.29 (2), p.99-111

Nagatsu, Toshiharu

1997

Volltextzugriff (PDF)

Peter Riederer, a translational neurobiochemist

Journal of Neural Transmission, 2022-06, Vol.129 (5-6), p.443-444

2022

Volltextzugriff (PDF)

Phosphorylation of the N-terminal portion of tyrosine hydroxylase triggers proteasomal digestion of the enzyme

Biochemical and biophysical research communications, 2011-04, Vol.407 (2), p.343-347

2011

Volltextzugriff (PDF)

Human tyrosine hydroxylase in Parkinson’s disease and in related disorders

Journal of Neural Transmission, 2019-04, Vol.126 (4), p.397-409

2019

Volltextzugriff (PDF)

1 – 25 von 1.003

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(632)
Mit Volltextzugriff
(964)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(985)
Japanisch
(26)

Erscheinungsjahr

n.n

Thema

Science & Technology
(470)
Life Sciences & Biomedicine
(425)
Animals
(308)
Humans
(240)
Biological And Medical Sciences
(228)
Biochemistry & Molecular Biology
(174)
Neurosciences & Neurology
(174)
Neurosciences
(170)
Rats
(151)
Fundamental And Applied Biological Sciences. Psychology
(142)
Male
(134)
Mice
(99)
Medical Sciences
(93)
Female
(79)
Kinetics
(73)
Tyrosine Hydroxylase
(73)
Tyrosine 3-Monooxygenase - Metabolism
(72)
Neurology
(65)
Biophysics
(60)
Brain - Enzymology
(55)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neuromelanin in Parkinson's Disease: Tyrosine Hydroxylase and Tyrosinase

NeuroPsychopharmacotherapy

Remembering Keisuke Fujita, M.D., Ph.D., President and Founder of Fujita Health University, and his contributions to medical science and education

Parkinson's Disease: Cells Succumbing to Lifelong Dopamine-Related Oxidative Stress and Other Bioenergetic Challenges

The Life and Science of Professor Tsuneko Okazaki, and her time at Fujita Health University

L-dopa therapy for Parkinson's disease: Past, present, and future

Human tyrosine hydroxylase in Parkinson’s disease and in related disorders

Catecholamines and Parkinson’s disease: tyrosine hydroxylase (TH) over tetrahydrobiopterin (BH4) and GTP cyclohydrolase I (GCH1) to cytokines, neuromelanin, and gene therapy: a historical overview

In memory of Professor Leonor Michaelis in Nagoya: Great contributions to biochemistry in Japan in the first half of the 20th century

Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains

Identification by nano-LC-MS/MS of NT5DC2 as a protein binding to tyrosine hydroxylase: Down-regulation of NT5DC2 by siRNA increases catecholamine synthesis in PC12D cells

Salivary neopterin and related pterins: their comparison to those in plasma and changes in individuals

Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson’s disease (PD): historical overview and future prospects

Hypothesis: neural mechanism of psychotherapy for the treatment of Parkinson’s disease: cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), and Morita therapy?

Marshall Warren Nirenberg, Honorary member of JSN: Nobel Laureate and Giant of Science

The catecholamine system in health and disease: Relation to tyrosine 3-monooxygenase and other catecholamine-synthesizing enzymes

A link between stress and depression: Shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression

NT5DC2 affects the phosphorylation of tyrosine hydroxylase regulating its catalytic activity

Inhibition of deubiquitinating activity of USP14 decreases tyrosine hydroxylase phosphorylated at Ser19 in PC12D cells

Correction to: Hypothesis: neural mechanism of psychotherapy for the treatment of Parkinson’s disease: cognitive behavioral therapy (CBT), acceptance and commitment therapy (ACT), and Morita therapy?

Prolyl oligopeptidase and dipeptidyl peptidase II/dipeptidyl peptidase IV ratio in the cerebrospinal fluid in Parkinson’s disease: historical overview and future prospects

Isoquinoline neurotoxins in the brain and Parkinson's disease

Peter Riederer, a translational neurobiochemist

Phosphorylation of the N-terminal portion of tyrosine hydroxylase triggers proteasomal digestion of the enzyme

Human tyrosine hydroxylase in Parkinson’s disease and in related disorders

Suchergebnisse filtern